×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Gupta Suneel

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerFeb 26, 2024Option Exercise$29.534,282126,447183,285Feb 28, 2024, 08:00 PM
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerJan 09, 2024Option Exercise$7.385,00036,900192,567Jan 11, 2024, 08:00 PM
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerJan 09, 2024Sale$25.005,000125,000187,567Jan 11, 2024, 08:00 PM
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerOct 19, 2023Option Exercise$7.3820,000147,600168,317Oct 23, 2023, 04:31 PM
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerMay 31, 2023Option Exercise$26.074,150108,190148,037Jun 02, 2023, 07:51 PM
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerApr 26, 2022Option Exercise$7.3840,000295,200117,561Apr 26, 2022, 09:42 PM
PTGXProtagonist Therapeutics, IncGupta SuneelChief Development OfficerFeb 28, 2022Option Exercise$24.2864915,75877,007Mar 02, 2022, 08:40 PM
PTGXProtagonist Therapeutics, IncGupta SuneelEVP Clinical OperationsDec 03, 2019Buy$5.1330,000153,90049,500Dec 03, 2019, 06:32 PM